logo
logo
  • Home
    • Home 1
    • Home 2
    • Home 3
    • Home 4
  • Pages
    • About us
    • Partner
    • Our Team
    • Faq
    • Error
  • Career
    • Career
    • Job Description
  • Research
    • Research & Development
    • Research Details
    • Product Pipeline
    • Invester
    • Scientific Platform
  • Shop
    • Shop
    • Product Details
    • Cart Page
    • Checkout Page
  • News
    • Masonry
      • Style one
      • Style two
    • Without Grid
      • Style one
      • Style two
    • Default Layout
      • Style one
      • Style two
    • News Details
  • Contact
  • Log In /
  • Sing Up

Welcome back

To keep connected with us please login with your personal info

Create account


Or

  • Sign in with facebook
  • Sign in with google

Log In

Forget password ?
  • Sign in with facebook
  • Sign in with google
New User ?
Create a new account

Hi Dear ? Sign up to join us

Scientific Platform

  • Home
  • Scientific Platform

Technologies

We are Developing Life-Changing Therapies Through the Use of Our Proprietary Technologies.

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form.

It uses a dictionary of over 200 Latin words, combined with a handful of model sentence structures, to generate Lorem Ipsum which looks reasonable.

Focus

Jozicular Oncology’s goal is to eradicate cancer by developing personalized immunotherapies to fight multiple cancer types. Our approach focuses on the individual nature of a patient’s tumor and seeks.

These antigens, called tumor-specific neoantigens, offer attractive therapeutic targets because they are non-self and tumor-specific, and are key targets.

Unique Approach

PolyXen™

XCART Platform

XBIO-101 (sodium cridanimod)

Anti C5a Technology

Our Therapy

Routine Biopsy

Routine FFPE clinical biopsy as input material

Neoantigen Prediction

Jozicular EDGE™ AI model for tumor antigen prediction

Sequencing

Tumor exome Normal exome Tumor transcriptome

Immunotherapy

Patient specific predicted neoantigens inserted

Our Gallary

Subscribe Our Newsletter

To receive email releases, simply provide us with your email address below.

footer logo

Jozicular is a clinical-stage immuno-oncology company dedicated to making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases.

Ouick links
  • Career
  • Technology
  • News
  • Contact
  • Pipeline
  • About Us
  • Therapy
Contact Us
  • Collins Street West 8007, San Fransico, United States.
  • Jozicular@gmail.com
  • +09876923
Social Media
© Jozicular All right reserved. Powered with by Zwin